UPL Q2 FY27 Earnings Call: Reaffirms 7-11% Revenue Growth, Margin Streak Hits Eight Quarters

UPL Ltd held its Q2 FY27 earnings call on November 02, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Margin Streak Extends to Eight Quarters Despite Revenue Dip

• Q2 FY27 revenue of Rs.11,860 crore, ~1% lower YoY — volumes -10%, pricing flat, currency +9%; management noted crop protection volumes have partly been phased into H2 FY27.
• Eighth consecutive quarter of EBITDA margin improvement — Q2 FY27 EBITDA +5% to Rs.2,312 crore (margin +120 bps to 19.5%); H1 FY27 EBITDA +9% to Rs.3,812 crore (margin +80 bps to 17.3%), despite higher input, freight and energy costs.
• Q2 FY27 contribution +1% to Rs.5,087 crore — margin +100 bps to 42.9%; SG&A -2% YoY at Rs.2,775 crore on cost optimization.
• Q2 FY27 operational PATMI of Rs.422 crore — Rs.11 crore ahead of prior year; H1 FY27 operational PATMI (adjusted for exceptionals) +33% to Rs.441 crore on margin-led EBITDA growth and a lower effective tax rate.
• H1 FY27 free cash flow to equity of Rs.508 crore vs Rs.1,733 crore prior year — reflecting Rs.703 crore of higher planned capex/growth investment and a Rs.742 crore one-time tax refund in the prior-year base.
• Net working capital at 145 days, +27 days YoY — inventory +16, receivables +4, payables -6; TTM net debt/EBITDA rose to 2.9x from 2.7x.

Superform and Advanta Lead; Global Crop Protection Under Pressure

• Superform Q2 FY27 revenue +28% to Rs.3,579 crore — pricing +26%, volumes +2%; specialty chemicals +50% (volumes +33%), now 29% of platform revenue vs 25% a year ago; EBIT +39% to Rs.323 crore (margin +70 bps to 9%).
• UPL Corp (global crop protection) Q2 FY27 revenue -8% to Rs.7,972 crore — volumes -16%, pricing -2%, currency +10%; EBITDA margin 13.6%. North America grew on new products (Sonic Boom, Elevate); Brazil/LATAM hit by El Niño, fungicide declines and credit constraints; Europe heat wave hit fungicides.
• UPL SaaS (India crop protection) Q2 FY27 revenue +1% to Rs.921 crore — volumes -8% on dry spells, pricing +9%; H1 FY27 EBITDA +20% to Rs.553 crore (margin +430 bps to 26.8%); hyperscale brands (Centurion, Panora Easy, Brucia, Hermitree) +80% YoY in H1 FY27.
• Advanta Q2 FY27 revenue +12% to Rs.1,875 crore — field corn in Argentina/rest of LATAM/Indonesia, sunflower and grain sorghum in Argentina; EBITDA +19% to Rs.510 crore (margin +150 bps to 27.2%).
• Advanta India likely at most flat in Q2 FY27 — corn prices nearly doubled from Rs.1,600 to Rs.3,000/quintal vs opening, encouraging farmers in coastal Andhra and Tamil Nadu; growth expected to pick up from Q4 FY 2026-2027 onward.
• Analyst-cited H1 FY27 degrowth (Tarang Agarwal, Old Bridge) — global crop protection volumes ~-12%, SAS ~-8%, Super Coms' agricultural intermediates ~-6.5-7%; inventory position inched up reasonably as of 30 September 2026.

Employee Costs Down 15%; Glufosinate Uplift Seen as Structural

• Q2 FY27 employee costs fell ~15% YoY to Rs.1,240 crore — driven by GBS leverage (headcount up ~3x over the last two years through FY 2026-2027, work shifted to Pune and Mauritius), FX tailwinds, and the target operating model revamp (one-time costs booked in FY 2025-2026, benefits accruing in FY 2026-2027).
• CFO cautioned only part of the Rs.1,240 crore is a sustainable run-rate — part of the quarter's figure was FX-related; additional FY 2026-2027 cost initiatives are expected to take costs further down.
• Glufosinate prices from China have risen sharply over the last three months — CEO Raj Tiwari said this restores "some parity" for UPL, which previously lacked a level playing field.
• Pass-through is lagged — much buying occurred at lower prices in Feb-Mar 2026 (Q4 FY 2025-2026); new pricing is taking effect in parts of Asia, with the bigger volume unlock expected once older low-cost material in Latin America and the US clears.
• Broad-based China price upcycle described as structural — Ashish Jowal cited Chinese ag chem losses for several quarters, stricter environmental compliance, a "one company, one brand" policy and capacity discipline, and expects the glufosinate pattern to repeat across many other products coming out of China.
• India Crop Protection delivered ~20% EBITDA growth in H1 FY27 despite El Niño volume softness — CEO Ravishankar Cherukuri attributed this to higher-margin new launches (below internal targets) and timely price increases; the price-led benefit will fade as costs catch up, with a healthy EBITDA increase expected by end of FY 2026-2027 (not quantified).

Debt Maturities Cleared to March 2027; New "Structural Debt" Metric Introduced

• Net debt ~$3 billion at end-September 2026, $312 million higher YoY — on working capital, planned capex and JV/associate investments; TTM net debt/EBITDA 2.9x vs 2.7x prior year.
• December 2026 maturity fully addressed — of the $500 million term loan due Q3 FY 2026-2027, $400 million was refinanced to FY32 (rate undisclosed; CFO cited "excellent pricing in the current environment") and $100 million was prepaid using existing lines.
• No debt obligations remain until March 2027 — the next obligation falls in FY28 at ~$776 million ($500 million term loan plus ~$276 million bonds), all within the next 18 months; on the $278 million bond maturing in 2028, management said it is too early to decide (~18 months away) with all options open.
• New "structural debt" metric of ~$800 million as of 30 September 2026 — vs reported net debt ~$3 billion (~0.7x gearing, flat vs March); management framed it as a supplementary analytical view, not a substitute for reported leverage metrics or lender covenants, with focus staying on reducing reported net debt.
• Medium-term gearing guidance retained at 1.5x — net debt/EBITDA ended FY 2025-2026 at ~1.6x; management said it is "extremely difficult" to guide near-term net debt given volatility over the next 5-6 months, with Q3 FY 2026-2027 grower demand in key markets to determine year-end working capital.
• Factoring at end of H1 FY27 was ~$70 million lower than H1 FY 2025-2026 — per CFO Bikash Prasad; FY 2026-2027 capex plus investment guided at ~$425 million, with higher growth capex committed across capacity expansion, backward integration and entry into a biofuel complex.

Egypt Acquisition, Reorganization and Governance Moves

• Advanta to acquire 99.98% of Mish High Tech Seed International (Egypt) for ~$110 million — subject to closing conditions and still under regulatory approval as of Q2 FY27; no EBITDA or multiple disclosed (seller declined, citing commercial sensitivities); management called the deal "very value accretive," adding tropical corn and sorghum germplasm diversity and a northern Africa growth platform.
• Africa framed as a ~$1 billion organized commercial seed market — Advanta CEO Bhupen noted it is the only continent where population growth is likely to continue "10, 20 years down the line."
• Reorganization (announced February 2026) has approvals from regulators, lenders and the Competition Commission of India — no timeline offered for shareholder voting; on the stock's decline since the announcement, CFO Bikash Prasad said market feedback is shared with the board and the "board can take decisions," but declined to comment on whether the transaction is going ahead.
• Auditor transition to EY — KPMG/BSR is completing its 10-year term (reappointment not permitted); after an RFP process, EY was appointed as single auditor for the group and all platforms/entities globally, subject to shareholder approval.
• LIC-nominated Mr. Shatmanju Srivastava appointed additional director effective November 2, 2026 — non-executive, non-independent, subject to shareholder approval; management framed it as governance strengthening and said not to read too much into the timing.
• Exceptionals scrutiny addressed — the CFO said the Rs.75 crore other-income reversal relates to a provision always held within operational working capital, and the Rs.57 crore settlement under take-or-pay tolling arrangements is "very much part of the operational performance"; an analyst flagged the ~Rs.130 crore combined vs Rs.420 crore of group PAT. Management does not foresee further exceptional items unless required by accounting standards.
• Associate losses narrowing — Rs.130 crore loss impact in Q2 FY27 income from associates; annual associate losses cut from $58 million (FY 2024-2025) to $22 million in FY 2025-2026; JVs/associates expected to earn only ~4-5% distribution margins and stay within break-even to $10 million loss range (period unspecified).

FY27 Guidance Reaffirmed; "Super El Niño" the Key Swing Factor

• FY 2026-2027 guidance reaffirmed: 7-11% revenue growth and 10-14% EBITDA growth — originally given at Q1 FY27; CFO reiterated comfort as of the H1 FY27 close, subject to how macro conditions unfold.
• H1 FY27 delivered +4% revenue and +9% EBITDA — H1 is seasonally smaller, with ~40% of FY27 revenue in H1 and ~60% in H2.
• El Niño expected to intensify into a "super El Niño" between November and March (H2 FY27) — a definite concern for Latin America, Australia and Brazil; no timeline offered for when El Niño effects normalize in the financials. Guidance assumptions are no further adverse weather and no major escalation in the West Asia conflict.
• Selective H2 FY27 mitigation — targeting pockets expected to receive decent rainfall (Central America, Chile, western Africa, parts of the US, southern Brazil) and pushing bio solutions from the NPV/NPP platform into drought-stressed areas; volume increases expected across Americas, Europe and Africa as H2 seasons start, softened by costs not coming down anytime soon.
• Macro tailwind in agri commodities — soybean, wheat, corn and cotton prices up ~25-35% over the last 12 months with channel inventories broadly normal; management expects gradual improvement in grower sentiment and farm economics into H2 FY27.
• FY 2027-2028 guidance withheld — management said it is too early, but asserted that irrespective of global headwinds, UPL will do better than other players across all platforms; on the margin streak, the CFO pointed to comfort with existing FY 2026-2027 guidance rather than upgrading it.